Apollomics Inc. Warrant 2023-01.04.28 on Apollomics
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−28.2788 USD
−53.86 M USD
0.00 USD
6.38 K
About Apollomics Inc.
Sector
Industry
CEO
Hung Wen Chen
Website
Headquarters
Foster City
Founded
2015
Identifiers
3
ISIN KYG0411D1152
Apollomics, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of oncology therapies to address unmet medical needs. The company was founded by Liang Yu Guo and Sanjeev Redkar in May 2015 and is headquartered in Foster City, CA.
Displays a symbol's price movements over previous years to identify recurring trends.